M&A Deal Summary

Cell Microsystems Acquires Fluxion Biosciences

On August 23, 2023, Cell Microsystems acquired medical products company Fluxion Biosciences

Acquisition Highlights
  • This is Cell Microsystems’ 1st transaction in the Medical Products sector.
  • This is Cell Microsystems’ 1st transaction in the United States.
  • This is Cell Microsystems’ 1st transaction in California.

M&A Deal Summary

Date 2023-08-23
Target Fluxion Biosciences
Sector Medical Products
Buyer(s) Cell Microsystems
Deal Type Add-on Acquisition

Target

Fluxion Biosciences

Oakland, California, United States
Fluxion Biosciences is a developer of instruments and microfluidic chips for cell based drug assays. Fluxion Biosciences was founded in 2005 and is based in Oakland, California.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Cell Microsystems

Durham, North Carolina, United States

Category Company
Sector Life Science
DESCRIPTION

Cell Microsystems is a provider of pioneering solutions for cell biology research. Cell Microsystems enable complex workflows to be performed on a single consumable, including clonal propagation of single cells for CRISPR gene editing, cell line development, stem cell studies, organoids, and other 3D cultures, cell-based assays, and genomics research. Cell Microsystems is based in Durham, North Carolina.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1